Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- IV: 2 mcg/kg bolus followed by 0.01 mcg/kg/min continuous infusion. Adjust for hypotension. Last FDA-approved label 2009.
Dose evidence detail — Nesiritide
Detailed dose evidence documented for Nesiritide in its monograph — reference only, not dosing recommendations.
Reference only — not a dosing recommendation.
Studied in trials
Studied regimens (not recommendations)
Studied in trials — not a recommended dose
- VMAC: 2 mcg/kg bolus + 0.01 mcg/kg/min.
- Various studies examined lower doses (0.005 mcg/kg/min) for renal effects.
Not established
What is not established
- No established or recommended human dose for any indication (product discontinued / not recommended).
Nesiritide — secção de evidência de dose e administração da monografia